Search

5 result(s)

Light Medical, our new distributor for UK and Ireland
Light Medical was started by Mark Goodwin and Will Bryan in 2019 after working within the Nuclear Medicine sector for more than 10 years. The goal was to develop a progressive company that provides personalised solutions and builds relationships at every opportunity. Light Medical provides a platform for healthcare professionals to access international manufacturers and products that enables them to develop their service with the best possible tools. We look forward to a fruitful collaboration.
/en/news/83_light-medical-our-new-distributor-for-uk-and-ireland

Job offer - TECHNICIEN ASSURANCE QUALITE (FR-EN) (H/F/N)
for needed actions to support quality and business goals Ensure the rigorous application of standards and the compliance to specifications from a quality standpoint Help to define, develop, and maintain quality information records Maintain the
/en/news/42_job-offer-technicien-assurance-qualite-fr-en-hfn

PART TIME FINANCIAL MANAGER (2d/week)
Function: We are looking for a reliable Financial Manager that will analyze financial activities and subsequently provide advice and guidance to upper management on future financial plans. The goal is to enable the company’s leaders to make sound... insights and recommendations to upper management. Your guidance will empower the company’s leaders to make informed decisions that align with the organization’s long-term goals. Additionally, you will play a crucial role in developing and
/en/news/108_part-time-financial-manager-2dweek

PET Alpha-Sy project - PhD fellows in Organic Chemistry / Radiopharmaceutical Chemistry (more information)
protein α-synuclein is thought to be the hallmark for PD, but presently, there are no validated PET tracers available for visualization of pathogenic aggregates of this protein. Our scientific goal is to develop such tracer. A successful tracer will have a strong impact on PD-diagnosis and facilitate the development of effective disease modifying treatments. To reach our goals, it is necessary to train our early stage researchers in a highly interdisciplinary fashion spanning from chemistry, over
/en/news/33_pet-alpha-sy-project-phd-fellows-in-organic-chemistry-radiopharmaceutical-chemistry-more-information

Elysia, the start-up that has become a world leader
experienced extraordinary growth! For our second year, we have increased to over 4.5 million euros in sales. Our goal is to reach 7 million euros in sales in 2018. " (See article published in French on page 47 on the link below). Source :
/en/news/1_elysia-the-start-up-that-has-become-a-world-leader

Contact